- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Benefit of CoQ-10 in Patients on Statins (clinicaltrials.gov) - May 3, 2016
P=N/A, N=37, Completed, Not yet recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Dec 2017 Recruiting --> Completed | N=68 --> 37 | Trial primary completion date: Feb 2012 --> Jul 2014
- |||||||||| Rituxan (rituximab) / Roche
Enrollment change, Trial termination, Trial primary completion date: B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome (clinicaltrials.gov) - Apr 12, 2016 P2, N=8, Terminated, Recruiting --> Completed | N=68 --> 37 | Trial primary completion date: Feb 2012 --> Jul 2014 N=10 --> 8 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2016; Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up)
- |||||||||| Trial completion, Phase classification: Effect of American Ginseng on Exercise-induced Muscle Soreness (clinicaltrials.gov) - Mar 4, 2016
P1, N=10, Completed, N=10 --> 8 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Apr 2016; Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up) Available --> Completed | Phase classification: PN/A --> P1
- |||||||||| Trial completion, Enrollment change: Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) - Dec 10, 2015
P2, N=55, Completed, Available --> Completed | Phase classification: PN/A --> P1 Recruiting --> Completed | N=78 --> 55
- |||||||||| Enrollment closed, Trial primary completion date: Efficacy of Microcurrent Therapy After Eccentric Exercise (clinicaltrials.gov) - May 27, 2015
P=N/A, N=15, Active, not recruiting, Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> May 2015
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: CFS:M: Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder (clinicaltrials.gov) - Apr 13, 2015
P2, N=0, Withdrawn, Initiation date: Sep 2014 --> Aug 2015 | Trial primary completion date: Dec 2014 --> Dec 2015 N=24 --> 0 | Initiation date: Sep 2012 --> Mar 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2013
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise (clinicaltrials.gov) - Apr 8, 2015
P4, N=69, Completed, N=24 --> 0 | Initiation date: Sep 2012 --> Mar 2012 | Not yet recruiting --> Withdrawn | Trial primary completion date: Sep 2014 --> Feb 2013 Recruiting --> Completed | N=26 --> 69 | Trial primary completion date: Dec 2014 --> Sep 2014
- |||||||||| Enrollment change, Trial withdrawal, Trial primary completion date: Vitamin D Replacement in Statin-Induced Myopathy (clinicaltrials.gov) - Apr 7, 2015
P=N/A, N=0, Withdrawn, Recruiting --> Completed | N=26 --> 69 | Trial primary completion date: Dec 2014 --> Sep 2014 N=120 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2012 --> Jul 2012
- |||||||||| Caldolor (ibuprofen) / Grifols, Cumberland
Trial primary completion date: IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia (clinicaltrials.gov) - Mar 11, 2015 P4, N=14, Terminated, N=120 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2012 --> Jul 2012 Trial primary completion date: Dec 2014 --> Sep 2014
- |||||||||| Trial primary completion date: Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) - Mar 5, 2015
P2, N=78, Recruiting, Trial primary completion date: Dec 2014 --> Sep 2014 Trial primary completion date: Feb 2015 --> Dec 2015
- |||||||||| Trial primary completion date: Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) - Feb 27, 2015
P2, N=78, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2015 --> Feb 2015
- |||||||||| Trial primary completion date: Neurotropin Treatment of Fibromyalgia (clinicaltrials.gov) - Jan 2, 2015
P2, N=78, Recruiting, Recruiting --> Completed | N=230 --> 119 | Trial primary completion date: Aug 2014 --> Jan 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| Caldolor (ibuprofen) / Grifols, Cumberland
Enrollment change, Trial termination: IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia (clinicaltrials.gov) - Sep 28, 2014 P4, N=14, Terminated, Trial primary completion date: Feb 2014 --> Oct 2015 N=40 --> 14 | Recruiting --> Terminated; unable to increase to target enrollment
- |||||||||| Enbrel (etanercept) / Pfizer, Amgen, Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
Enrollment change, Trial termination: Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome (clinicaltrials.gov) - Sep 4, 2014 P2, N=4, Terminated, Trial primary completion date: Dec 2013 --> Dec 2015 N=15 --> 4 | Recruiting --> Terminated; After inclusion of four patients, two experienced moderate worsening of symptoms
|